D Conrad

All filings by D Conrad on record concern GlaxoSmithKline plc. Between 15 April 2019 and 6 July 2022, the trades on record add up to 89 filings.

The open-market record is one-sided, with 5 purchases worth €524k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 84 share grants.

In size, the median ticket on the buying side is €97k. Of 5 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 8 July 2022, reports a share grant of €119 in GlaxoSmithKline plc. The last purchase on record was published on 25 June 2021, which is 1,961 days ago. Filings reach the RNS (LSE) feed a median of 2 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.